Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith S Currier

Showing results (81-90 of 324) with videos related to

Pageof 33
Sort By:
BMC Health Services Research|May 14, 2026
High usage of telephone telemedicine among people living with HIV at two federally qualified health centers in Los AngelesRisa Hoffman, Daisy Walker, Derrick Butler, et al.
AIDS Patient Care and Stds|May 27, 2011
Effects of darunavir/ritonavir-based therapy on metabolic and anthropometric parameters in women and men over 48 weeksJudith S Currier, Claudia Martorell, Olayemi Osiyemi, et al.
Open Forum Infectious Diseases|November 23, 2018
Changes in Waist Circumference in HIV-Infected Individuals Initiating a Raltegravir or Protease Inhibitor Regimen: Effects of Sex and RacePriya Bhagwat, Ighovwerha Ofotokun, Grace A McComsey, et al.
HIV Clinical Trials|September 12, 2015
Telmisartan to reduce cardiovascular risk in older HIV-infected adults: a pilot studyJordan E Lake, Sophie Seang, Theodoros Kelesidis, et al.
Plos One|November 5, 2014
A high throughput biochemical fluorometric method for measuring lipid peroxidation in HDLTheodoros Kelesidis, Christian K Roberts, Diana Huynh, et al.
Open Forum Infectious Diseases|September 18, 2015
Switch to Raltegravir From Protease Inhibitor or Nonnucleoside Reverse-Transcriptase Inhibitor Does not Reduce Visceral Fat In Human Immunodeficiency Virus-Infected Women With Central AdiposityJordan E Lake, Grace A McComsey, Todd Hulgan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2003
Coronary heart disease in HIV-infected individualsJudith S Currier, Anne Taylor, Felicity Boyd, et al.
JAMA Network Open|October 27, 2022
Recurrence of Symptoms Following a 2-Day Symptom Free Period in Patients With COVID-19Davey M Smith, Jonathan Z Li, Carlee Moser, et al.
AIDS Research and Human Retroviruses|April 11, 2015
Short Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected PersonsKara W Chew, Debika Bhattacharya, Kathleen A McGinnis, et al.
Journal of Medical Virology|March 21, 2012
Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Los Angeles CountyTheodoros Kelesidis, Romney Humphries, Dawn Terashita, et al.
Pageof 33

Showing results (81-90 of 324) with videos related to

Sort By:
Pageof 33
BMC Health Services Research|May 14, 2026
High usage of telephone telemedicine among people living with HIV at two federally qualified health centers in Los AngelesRisa Hoffman, Daisy Walker, Derrick Butler, et al.
AIDS Patient Care and Stds|May 27, 2011
Effects of darunavir/ritonavir-based therapy on metabolic and anthropometric parameters in women and men over 48 weeksJudith S Currier, Claudia Martorell, Olayemi Osiyemi, et al.
Open Forum Infectious Diseases|November 23, 2018
Changes in Waist Circumference in HIV-Infected Individuals Initiating a Raltegravir or Protease Inhibitor Regimen: Effects of Sex and RacePriya Bhagwat, Ighovwerha Ofotokun, Grace A McComsey, et al.
HIV Clinical Trials|September 12, 2015
Telmisartan to reduce cardiovascular risk in older HIV-infected adults: a pilot studyJordan E Lake, Sophie Seang, Theodoros Kelesidis, et al.
Plos One|November 5, 2014
A high throughput biochemical fluorometric method for measuring lipid peroxidation in HDLTheodoros Kelesidis, Christian K Roberts, Diana Huynh, et al.
Open Forum Infectious Diseases|September 18, 2015
Switch to Raltegravir From Protease Inhibitor or Nonnucleoside Reverse-Transcriptase Inhibitor Does not Reduce Visceral Fat In Human Immunodeficiency Virus-Infected Women With Central AdiposityJordan E Lake, Grace A McComsey, Todd Hulgan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2003
Coronary heart disease in HIV-infected individualsJudith S Currier, Anne Taylor, Felicity Boyd, et al.
JAMA Network Open|October 27, 2022
Recurrence of Symptoms Following a 2-Day Symptom Free Period in Patients With COVID-19Davey M Smith, Jonathan Z Li, Carlee Moser, et al.
AIDS Research and Human Retroviruses|April 11, 2015
Short Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected PersonsKara W Chew, Debika Bhattacharya, Kathleen A McGinnis, et al.
Journal of Medical Virology|March 21, 2012
Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Los Angeles CountyTheodoros Kelesidis, Romney Humphries, Dawn Terashita, et al.
Pageof 33